FHIR Release 3 (STU) R4 Ballot #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.0.2: STU 3). (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

4.3.1.22 4.4.1.228 Value Set http://hl7.org/fhir/ValueSet/vaccine-code

Public Health and Emergency Response Work Group   Maturity Level : 1 Informative Draft Use Context : Not Intended for Production use

This is a value set defined by the FHIR project.

Summary

Defining URL: http://hl7.org/fhir/ValueSet/vaccine-code
Version: 3.5.0
Name: VaccineAdministeredValueSet
Title: Vaccine Administered Value Set
Definition:

This identifies the vaccine substance administered - CVX codes.

Committee: Public Health and Emergency Response Work Group
OID: 2.16.840.1.113883.3.88.12.80.22 (for OID based terminology systems)
Source Resource XML / JSON

This value set is used in the following places:

4.3.1.22.1 4.4.1.228.1 Content Logical Definition

This value set includes codes from the following code systems:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx
  • Include all codes defined in urn:oid:1.2.36.1.2001.1005.17

 

4.3.1.22.2 4.4.1.228.2 Expansion

This expansion generated 19 Apr 2017 Aug 2018

This value set contains 239 concepts Code System Display 01 http://hl7.org/fhir/sid/cvx DTP 02 http://hl7.org/fhir/sid/cvx OPV 03 http://hl7.org/fhir/sid/cvx MMR 04 http://hl7.org/fhir/sid/cvx M/R 05 http://hl7.org/fhir/sid/cvx measles 06 http://hl7.org/fhir/sid/cvx rubella 07 http://hl7.org/fhir/sid/cvx mumps 08 http://hl7.org/fhir/sid/cvx Hep B, adolescent or pediatric 09 http://hl7.org/fhir/sid/cvx Td (adult), adsorbed 10 http://hl7.org/fhir/sid/cvx IPV 100 http://hl7.org/fhir/sid/cvx pneumococcal conjugate PCV 7 101 http://hl7.org/fhir/sid/cvx typhoid, ViCPs 102 http://hl7.org/fhir/sid/cvx DTaP/DTP-Hib-Hep B 103 http://hl7.org/fhir/sid/cvx meningococcal C conjugate 104 http://hl7.org/fhir/sid/cvx Hep A-Hep B 105 http://hl7.org/fhir/sid/cvx vaccinia (smallpox) diluted 106 http://hl7.org/fhir/sid/cvx DTaP, 5 pertussis antigens 107 http://hl7.org/fhir/sid/cvx DTaP, unspecified formulation 108 http://hl7.org/fhir/sid/cvx meningococcal, unspecified formulation 109 http://hl7.org/fhir/sid/cvx pneumococcal, unspecified formulation 11 http://hl7.org/fhir/sid/cvx pertussis 110 http://hl7.org/fhir/sid/cvx DTaP-Hep B-IPV 111 http://hl7.org/fhir/sid/cvx influenza, live, intranasal 112 http://hl7.org/fhir/sid/cvx tetanus toxoid, unspecified formulation 113 http://hl7.org/fhir/sid/cvx Td (adult) preservative free 114 http://hl7.org/fhir/sid/cvx meningococcal MCV4P 115 http://hl7.org/fhir/sid/cvx Tdap 116 http://hl7.org/fhir/sid/cvx rotavirus, pentavalent 117 http://hl7.org/fhir/sid/cvx VZIG (IND) 118 http://hl7.org/fhir/sid/cvx HPV, bivalent 119 http://hl7.org/fhir/sid/cvx rotavirus, monovalent 12 http://hl7.org/fhir/sid/cvx diphtheria antitoxin 120 http://hl7.org/fhir/sid/cvx DTaP-Hib-IPV 121 http://hl7.org/fhir/sid/cvx zoster 122 http://hl7.org/fhir/sid/cvx rotavirus, unspecified formulation 123 http://hl7.org/fhir/sid/cvx influenza, H5N1-1203 125 http://hl7.org/fhir/sid/cvx Novel Influenza-H1N1-09, nasal 126 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09, preservative-free 127 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09 128 http://hl7.org/fhir/sid/cvx Novel Influenza-H1N1-09, all formulations 129 http://hl7.org/fhir/sid/cvx Japanese Encephalitis, unspecified formulation 13 http://hl7.org/fhir/sid/cvx TIG 130 http://hl7.org/fhir/sid/cvx DTaP-IPV 131 http://hl7.org/fhir/sid/cvx typhus, historical 132 http://hl7.org/fhir/sid/cvx DTaP-IPV-HIB-HEP B, historical 133 http://hl7.org/fhir/sid/cvx Pneumococcal conjugate PCV 13 134 http://hl7.org/fhir/sid/cvx Japanese Encephalitis IM 135 http://hl7.org/fhir/sid/cvx Influenza, high dose seasonal 136 http://hl7.org/fhir/sid/cvx Meningococcal MCV4O 137 http://hl7.org/fhir/sid/cvx HPV, unspecified formulation 138 http://hl7.org/fhir/sid/cvx Td (adult) 139 http://hl7.org/fhir/sid/cvx Td(adult) unspecified formulation 14 http://hl7.org/fhir/sid/cvx IG, unspecified formulation 140 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable, preservative free 141 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable 142 http://hl7.org/fhir/sid/cvx tetanus toxoid, not adsorbed 143 http://hl7.org/fhir/sid/cvx Adenovirus types 4 and 7 144 http://hl7.org/fhir/sid/cvx influenza, seasonal, intradermal, preservative free 145 http://hl7.org/fhir/sid/cvx RSV-MAb (new) 146 http://hl7.org/fhir/sid/cvx DTaP,IPV,Hib,HepB 147 http://hl7.org/fhir/sid/cvx meningococcal MCV4, unspecified formulation 148 http://hl7.org/fhir/sid/cvx Meningococcal C/Y-HIB PRP 149 http://hl7.org/fhir/sid/cvx influenza, live, intranasal, quadrivalent 15 http://hl7.org/fhir/sid/cvx influenza, split (incl. purified surface antigen) 150 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent, preservative free 151 http://hl7.org/fhir/sid/cvx influenza nasal, unspecified formulation 152 http://hl7.org/fhir/sid/cvx Pneumococcal Conjugate, unspecified formulation 153 http://hl7.org/fhir/sid/cvx Influenza, injectable, MDCK, preservative free 154 http://hl7.org/fhir/sid/cvx Hep A, IG 155 http://hl7.org/fhir/sid/cvx influenza, recombinant, injectable, preservative free 156 http://hl7.org/fhir/sid/cvx Rho(D)-IG 157 http://hl7.org/fhir/sid/cvx Rho(D) -IG IM 158 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent 159 http://hl7.org/fhir/sid/cvx Rho(D) - Unspecified formulation 16 http://hl7.org/fhir/sid/cvx influenza, whole 160 http://hl7.org/fhir/sid/cvx Influenza A monovalent (H5N1), ADJUVANTED-2013 161 http://hl7.org/fhir/sid/cvx Influenza, injectable,quadrivalent, preservative free, pediatric 162 http://hl7.org/fhir/sid/cvx meningococcal B, recombinant 163 http://hl7.org/fhir/sid/cvx meningococcal B, OMV 164 http://hl7.org/fhir/sid/cvx meningococcal B, unspecified 17 http://hl7.org/fhir/sid/cvx Hib, unspecified formulation 18 http://hl7.org/fhir/sid/cvx rabies, intramuscular injection 19 http://hl7.org/fhir/sid/cvx BCG 20 http://hl7.org/fhir/sid/cvx DTaP 21 http://hl7.org/fhir/sid/cvx varicella 22 http://hl7.org/fhir/sid/cvx DTP-Hib 23 http://hl7.org/fhir/sid/cvx plague 24 http://hl7.org/fhir/sid/cvx anthrax 25 http://hl7.org/fhir/sid/cvx typhoid, oral 26 http://hl7.org/fhir/sid/cvx cholera 27 http://hl7.org/fhir/sid/cvx botulinum antitoxin 28 http://hl7.org/fhir/sid/cvx DT (pediatric) 29 http://hl7.org/fhir/sid/cvx CMVIG 30 http://hl7.org/fhir/sid/cvx HBIG 31 http://hl7.org/fhir/sid/cvx Hep A, pediatric, unspecified formulation 32 http://hl7.org/fhir/sid/cvx meningococcal MPSV4 33 http://hl7.org/fhir/sid/cvx pneumococcal polysaccharide PPV23 34 http://hl7.org/fhir/sid/cvx RIG 35 http://hl7.org/fhir/sid/cvx tetanus toxoid, adsorbed 36 http://hl7.org/fhir/sid/cvx VZIG 37 http://hl7.org/fhir/sid/cvx yellow fever 38 http://hl7.org/fhir/sid/cvx rubella/mumps 39 http://hl7.org/fhir/sid/cvx Japanese encephalitis SC 40 http://hl7.org/fhir/sid/cvx rabies, intradermal injection 41 http://hl7.org/fhir/sid/cvx typhoid, parenteral 42 http://hl7.org/fhir/sid/cvx Hep B, adolescent/high risk infant 43 http://hl7.org/fhir/sid/cvx Hep B, adult 44 http://hl7.org/fhir/sid/cvx Hep B, dialysis 45 http://hl7.org/fhir/sid/cvx Hep B, unspecified formulation 46 http://hl7.org/fhir/sid/cvx Hib (PRP-D) 47 http://hl7.org/fhir/sid/cvx Hib (HbOC) 48 http://hl7.org/fhir/sid/cvx Hib (PRP-T) 49 http://hl7.org/fhir/sid/cvx Hib (PRP-OMP) 50 http://hl7.org/fhir/sid/cvx DTaP-Hib 51 http://hl7.org/fhir/sid/cvx Hib-Hep B 52 http://hl7.org/fhir/sid/cvx Hep A, adult 53 http://hl7.org/fhir/sid/cvx typhoid, parenteral, AKD (U.S. military) 54 http://hl7.org/fhir/sid/cvx adenovirus, type 4 55 http://hl7.org/fhir/sid/cvx adenovirus, type 7 56 http://hl7.org/fhir/sid/cvx dengue fever 57 http://hl7.org/fhir/sid/cvx hantavirus 58 http://hl7.org/fhir/sid/cvx Hep C 59 http://hl7.org/fhir/sid/cvx Hep E 60 http://hl7.org/fhir/sid/cvx herpes simplex 2 61 http://hl7.org/fhir/sid/cvx HIV 62 http://hl7.org/fhir/sid/cvx HPV, quadrivalent 63 http://hl7.org/fhir/sid/cvx Junin virus 64 http://hl7.org/fhir/sid/cvx leishmaniasis 65 http://hl7.org/fhir/sid/cvx leprosy 66 http://hl7.org/fhir/sid/cvx Lyme disease 67 http://hl7.org/fhir/sid/cvx malaria 68 http://hl7.org/fhir/sid/cvx melanoma 69 http://hl7.org/fhir/sid/cvx parainfluenza-3 70 http://hl7.org/fhir/sid/cvx Q fever 71 http://hl7.org/fhir/sid/cvx RSV-IGIV 72 http://hl7.org/fhir/sid/cvx rheumatic fever 73 http://hl7.org/fhir/sid/cvx Rift Valley fever 74 http://hl7.org/fhir/sid/cvx rotavirus, tetravalent 75 http://hl7.org/fhir/sid/cvx vaccinia (smallpox) 76 http://hl7.org/fhir/sid/cvx Staphylococcus bacterio lysate 77 http://hl7.org/fhir/sid/cvx tick-borne encephalitis 78 http://hl7.org/fhir/sid/cvx tularemia vaccine 79 http://hl7.org/fhir/sid/cvx vaccinia immune globulin 80 http://hl7.org/fhir/sid/cvx VEE, live 801 http://hl7.org/fhir/sid/cvx AS03 Adjuvant 81 http://hl7.org/fhir/sid/cvx VEE, inactivated 82 http://hl7.org/fhir/sid/cvx adenovirus, unspecified formulation 83 http://hl7.org/fhir/sid/cvx Hep A, ped/adol, 2 dose 84 http://hl7.org/fhir/sid/cvx Hep A, ped/adol, 3 dose 85 http://hl7.org/fhir/sid/cvx Hep A, unspecified formulation 86 http://hl7.org/fhir/sid/cvx IG 87 http://hl7.org/fhir/sid/cvx IGIV 88 http://hl7.org/fhir/sid/cvx influenza, unspecified formulation 89 http://hl7.org/fhir/sid/cvx polio, unspecified formulation 90 http://hl7.org/fhir/sid/cvx rabies, unspecified formulation 91 http://hl7.org/fhir/sid/cvx typhoid, unspecified formulation 92 http://hl7.org/fhir/sid/cvx VEE, unspecified formulation 93 http://hl7.org/fhir/sid/cvx RSV-MAb 94 http://hl7.org/fhir/sid/cvx MMRV 95 http://hl7.org/fhir/sid/cvx TST-OT tine test 96 http://hl7.org/fhir/sid/cvx TST-PPD intradermal 97 http://hl7.org/fhir/sid/cvx TST-PPD tine test 98 http://hl7.org/fhir/sid/cvx TST, unspecified formulation 99 http://hl7.org/fhir/sid/cvx RESERVED - do could not use 998 http://hl7.org/fhir/sid/cvx no vaccine administered 999 be expanded by the publication tooling: Error unmarshalling resource: Unable to provide support for code system http://hl7.org/fhir/sid/cvx unknown AGRPAL urn:oid:1.2.36.1.2001.1005.17 Agrippal AVAXM urn:oid:1.2.36.1.2001.1005.17 Avaxim BCG urn:oid:1.2.36.1.2001.1005.17 BCG CDT urn:oid:1.2.36.1.2001.1005.17 CDT CMX urn:oid:1.2.36.1.2001.1005.17 COMVAX DTP urn:oid:1.2.36.1.2001.1005.17 Triple Antigen DTPA urn:oid:1.2.36.1.2001.1005.17 DTPa ENGP urn:oid:1.2.36.1.2001.1005.17 Engerix B FLRIX urn:oid:1.2.36.1.2001.1005.17 Fluarix FLUVAX urn:oid:1.2.36.1.2001.1005.17 Fluvax FLVRN urn:oid:1.2.36.1.2001.1005.17 Fluvirin FVXJNR urn:oid:1.2.36.1.2001.1005.17 Fluvax Junior GNDIP urn:oid:1.2.36.1.2001.1005.17 Diphtheria GNFLU urn:oid:1.2.36.1.2001.1005.17 Influenza GNHEP urn:oid:1.2.36.1.2001.1005.17 Hepatitis B GNHIB urn:oid:1.2.36.1.2001.1005.17 HIB GNHPA urn:oid:1.2.36.1.2001.1005.17 Hepatitis A GNJEN urn:oid:1.2.36.1.2001.1005.17 Japanese Encephalitis GNMEA urn:oid:1.2.36.1.2001.1005.17 Measles GNMEN urn:oid:1.2.36.1.2001.1005.17 Meningococcal C GNMUM urn:oid:1.2.36.1.2001.1005.17 Mumps GNPNE urn:oid:1.2.36.1.2001.1005.17 Pneumococcal GNPOL urn:oid:1.2.36.1.2001.1005.17 Polio GNROX urn:oid:1.2.36.1.2001.1005.17 Rotavirus GNRUB urn:oid:1.2.36.1.2001.1005.17 Rubella GNTET urn:oid:1.2.36.1.2001.1005.17 Tetanus GNVAR urn:oid:1.2.36.1.2001.1005.17 Varicella HATWNJ urn:oid:1.2.36.1.2001.1005.17 Twinrix Junior HAVAQ urn:oid:1.2.36.1.2001.1005.17 Vaqta Paed/Adol HAVJ urn:oid:1.2.36.1.2001.1005.17 Havrix Junior HBOC urn:oid:1.2.36.1.2001.1005.17 HibTITER HBV urn:oid:1.2.36.1.2001.1005.17 HBV HBVP urn:oid:1.2.36.1.2001.1005.17 HBVAX II HBX urn:oid:1.2.36.1.2001.1005.17 Hiberix IFHX urn:oid:1.2.36.1.2001.1005.17 Infanrix Hexa IFIP urn:oid:1.2.36.1.2001.1005.17 Infanrix-IPV IFPA urn:oid:1.2.36.1.2001.1005.17 Infanrix Penta IFX urn:oid:1.2.36.1.2001.1005.17 Infanrix IFXB urn:oid:1.2.36.1.2001.1005.17 InfanrixHepB INFLUV urn:oid:1.2.36.1.2001.1005.17 Influvac IPV urn:oid:1.2.36.1.2001.1005.17 IPOL JEVAX urn:oid:1.2.36.1.2001.1005.17 JE-VAX MENJUG urn:oid:1.2.36.1.2001.1005.17 Menjugate MENTEC urn:oid:1.2.36.1.2001.1005.17 Meningitec MENUME urn:oid:1.2.36.1.2001.1005.17 Menomune MENVAX urn:oid:1.2.36.1.2001.1005.17 Mencevax ACWY MMR urn:oid:1.2.36.1.2001.1005.17 MMR MMRCSL urn:oid:1.2.36.1.2001.1005.17 MMR II MMRSKB urn:oid:1.2.36.1.2001.1005.17 Priorix MNTRX urn:oid:1.2.36.1.2001.1005.17 Menitorix NEISVC urn:oid:1.2.36.1.2001.1005.17 NeisVac-C OPV urn:oid:1.2.36.1.2001.1005.17 Polio P urn:oid:1.2.36.1.2001.1005.17 Pertussis PANVAX urn:oid:1.2.36.1.2001.1005.17 Panvax PDCL urn:oid:1.2.36.1.2001.1005.17 Pediacel PLCL urn:oid:1.2.36.1.2001.1005.17 Poliacel PNEUMO urn:oid:1.2.36.1.2001.1005.17 Pneumovax PRPD urn:oid:1.2.36.1.2001.1005.17 ProHIBit PROQAD urn:oid:1.2.36.1.2001.1005.17 ProQuad PRPOMP urn:oid:1.2.36.1.2001.1005.17 PedvaxHIB PRPT urn:oid:1.2.36.1.2001.1005.17 ActHIB PRVNR urn:oid:1.2.36.1.2001.1005.17 Prevenar 7 PRVTH urn:oid:1.2.36.1.2001.1005.17 Prevenar 13 PRXTEX urn:oid:1.2.36.1.2001.1005.17 Priorix-Tetra QDCL urn:oid:1.2.36.1.2001.1005.17 Quadracel ROTRIX urn:oid:1.2.36.1.2001.1005.17 Rotarix ROTTEQ urn:oid:1.2.36.1.2001.1005.17 Rotateq SYNFLX urn:oid:1.2.36.1.2001.1005.17 Synflorix TCL urn:oid:1.2.36.1.2001.1005.17 Tripacel VAXGRP urn:oid:1.2.36.1.2001.1005.17 Vaxigrip VGRJNR urn:oid:1.2.36.1.2001.1005.17 Vaxigrip Junior VLRIX urn:oid:1.2.36.1.2001.1005.17 Varilrix VRVAX urn:oid:1.2.36.1.2001.1005.17 Varivax

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

Level Lvl A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes For value sets, levels are under other codes, and imply that the mostly used to organize codes for user convenience, but may follow code they are under also applies system hierarchy - see Code System for further information
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
Display The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code